Intracerebral hemorrhage

Neurologist

Volumn 11, Issue 6, 2005, Pages 311-324

  Badjatia, Neeraj ^a,b   Rosand, Jonathan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Intracerebral hemorrhage; Intracranial pressure; Intraventricular hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; APROTININ; BARBITURIC ACID DERIVATIVE; BLOOD CLOTTING FACTOR 9; CLOPIDOGREL; CORTICOSTEROID; DESMOPRESSIN; DIPYRIDAMOLE; ENALAPRILAT; FENOLDOPAM; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; HYDRALAZINE; LABETALOL; MANNITOL; NICARDIPINE; NITROPRUSSIDE SODIUM; PROTAMINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; UNINDEXED DRUG; VITAMIN K GROUP; WARFARIN;

ALCOHOL CONSUMPTION; ANGIONEUROTIC EDEMA; ANTICOAGULANT THERAPY; ANTICOAGULATION; BRADYCARDIA; BRAIN HEMORRHAGE; BRAIN INJURY; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; CRYOPRECIPITATE; DISABILITY; EMERGENCY WARD; EXTUBATION; FEVER; HEART BLOCK; HEMATOMA; HEMODYNAMICS; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERVENTILATION; HYPOTENSION; HYPOTHERMIA; HYPOXEMIA; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRACRANIAL TUMOR; KIDNEY FAILURE; MORBIDITY; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RACE; REVIEW; RISK FACTOR; SEIZURE; TACHYCARDIA; THERMOREGULATION; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; TOBACCO; TRACHEOSTOMY; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; EMERGENCY SERVICE, HOSPITAL; FACTOR VII; HUMANS; INTRACRANIAL PRESSURE; OSMOTIC PRESSURE; RISK FACTORS;

EID: 28044464946     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000178757.68551.26     Document Type: Review

References (159)

1. Kase CS, Mohr JP, Caplan LR. Intracerebral hemorrhage. In: Barnett H, Mohr J, Stein B, et al., eds. Stroke: Pathophysiology, Diagnosis and Management, 3rd ed. Philadelphia: Churchill Livingstone; 1998:649-700.
2. Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78:188-191.
3. Broderick JP, Brott T, Tomsick T, et al. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992;326:733-736.
4. Counsell C, Boonyakarnkul S, Dennis M, et al. Primary intracerebral haemorrhage in the Oxfordshire Community Stroke Project 2. Prognosis. Cerebrovasc Dis. 1995;5:26-34.
5. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 1999;30:905-915.
6. Rosand JE, MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. In press.
7. Broderick J, Brott T, Tomsick T, et al. Lobar hemorrhage in the elderly. The undiminishing importance of hypertension. Stroke. 1993;24:49-51.
8. Furlan AJ, Whisnant JP, Elveback LR. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol. 1979;5:367-373.
9. Broderick JP. Natural history of primary intracerebral hemorrhage. In: Whisnant JP, ed. Stroke: Populations, Cohorts and Clinical Trials. Oxford: Butterworth-Heinmann; 1993:154-173.
10. Broderick JP, Phillips SJ, Whisnant JP, et al. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989;20:577-582.
11. Fogelholm R, Nuutila M, Vuorela AL. Primary intracerebral haemorrhage in the Jyvaskyla region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry. 1992;55:546-552.
12. Giroud M, Creisson E, Fayolle H, et al. Risk factors for primary cerebral hemorrhage: a population-based study - the Stroke Registry of Dijon. Neuroepidemiology. 1995;14:20-26.
13. Qureshi AI, Suri MA, Safdar K, et al. Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome. Stroke. 1997;28:961-964.
14. Suzuki K, Kutsuzawa T, Takita K, et al. Clinico-epidemiologic study of stroke in Akita, Japan. Stroke. 1987;18:402-406.
15. Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986;45:79-90.
16. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30:637-649.
17. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain II. The distribution of amyloid vascular changes. Stroke. 1983;14:924-928.
18. Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatric Soc. 1981;29:151-157.
19. Masuda J, Tanaka K, Ueda K, et al. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke. 1988;19:205-210.
20. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002;33:1190-1196; discussion 1190-1196.
21. Knudsen KA, Rosand J, Karluk D, et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56:537-539.
22. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342:240-245.
23. Rosand J, Greenberg SM. Cerebral amyloid angiopathy. Neurologist. 2000;6:315-325.
24. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction study: Thrombolysis in Myocardial Infarction, phase II, pilot and clinical trial. Circulation. 1991;83:448-459.
25. Alcohol and haemorrhagic stroke. Lancet. 1986;2:256-257.
26. Calandre L, Arnal C, Ortega JF, et al. Risk factors for spontaneous cerebral hematomas. Case-control study. Stroke. 1986;17:1126-1128.
27. Donahue RP, Abbott RD, Reed DM, et al. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA. 1986;255:2311-2314.
28. Weisberg LA. Alcoholic intracerebral hemorrhage. Stroke. 1988;19:1565-1569.
29. Monforte R, Estruch R, Graus F, et al. High ethanol consumption as risk factor for intracerebral hemorrhage in young and middle-aged people. Stroke. 1990;21:1529-1532.
30. Renaud SC, Ruf JC. Effects of alcohol on platelet functions. Clin Chim Acta. 1996;246:77-89.
31. Segal AZ, Chiu RI, Eggleston-Sexton PM, et al. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology. 1999;18:185-193.
32. Okumura K, Iseki K, Wakugami K, et al. Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan. Japanese Circulation Journal. 1999;63:53-58.
33. Zodpey SP, Tiwari RR, Kulkarni HR. Risk factors for haemorrhagic stroke: a case-control study. Public Health. 2000;114:177-182.
34. Iso H, Jacobs DJ, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904-910.
35. Puddey IB. Low serum cholesterol and the risk of cerebral haemorrhage. Atherosclerosis. 1996;119:1-6.
36. Ruiz-Sandoval JL, Cantu C, Barinagarrementeria F. Intracerebral hemorrhage in young people: analysis of risk factors, location, causes, and prognosis. Stroke. 1999;30:537-541.
37. Levine MN, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119:1088-1218.
38. Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 131:492-501.
39. JAMA. 281:1830-1835.
40. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.
41. Albers GW. Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: warfarin, aspirin, or both? Arch Intern Med. 1998;158:1487-1491.
42. Rosand J, Hylek EM, O'Donnell HC, et al. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology. 2000;55:947-951.
43. Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology: 2002;59:193-197.
44. Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-884.
45. Elkind MSV, Sacco RL. Direct thrombin inhibition: a novel approach to stroke prevention in patients with atrial fibrillation. Stroke. 2004;35:1519-1522.
46. De Smet Y, Brucher JM. Migraine with vasospasm and delayed intracerebral hemorrhage. Arch Neurol. 1991;48:17.
47. Nighoghossian N, Derex L, Trouillas P, et al. Multiple intracerebral hemorrhages and vasospasm following antimigrainous drug abuse. Headache. 1998;38:478-480.
48. Kalant H, Kalant OJ. Death in amphetamine users: causes and rates. Can Med Assoc J. 1975;112:299-304.
49. Sloan MA, Kittner SJ, Rigamonti D, et al. Occurrence of stroke associated with use/abuse of drugs. Neurology. 1991;41:1358-1364.
50. Tuchman AJ, Daras M, Zalzal P, et al. Intracranial hemorrhage after cocaine abuse. JAMA. 1987;257:1175.
51. Wojak JC, Flamm ES. Intracranial hemorrhage and cocaine use. Stroke. 1987;18:712-715.
52. Nolte KB, Gelman BB. Intracerebral hemorrhage associated with cocaine abuse. Arch Pathol Lab Med. 1989;113:812-813.
53. Dusick AM, Covert RF, Schreiber MD, et al. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. J Pediatr. 1993;122:438-445.
54. Forman HP, Levin S, Stewart B, et al. Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics. 1989;83:737-741.
55. Bernstein E, Diskant BM. Phenylpropanolamine: a potentially hazardous drug. Ann Emerg Med. 1982;11:311-315.
56. Glick R, Hoying J, Cerullo L, et al. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery. 1987;20:969-974.
57. Loizou LA, Hamilton JG, Tsementzis SA. Intracranial haemorrhage in association with pseudoephedrine overdose. J Neurol Neurosurg Psychiatry. 1982;45:471-472.
58. Yin PA. Ephedrine-induced intracerebral hemorrhage and central nervous system vasculitis. Stroke. 1990;21:1641.
59. Stoessl AJ, Young GB, Feasby TE. Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics. Stroke. 1985;16:734-736.
60. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 343;1826-1832.
61. Arteriovenous malformations of the brain in adults. N Engl J Med. 1999;340:1812-1818.
62. Kondziolka D, Lunsford LD, Flickinger JC, et al. Reduction of hemorrhage risk after stereotactic radiosurgery for cavernous malformations. J Neurosurg. 1995;83:825-831.
63. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83:820-824.
64. Wintermark MUA, Chalaron M, Regali L, et al. Multislice computer-ized tomography angiography in the evaluation of intracranial aneurysms: a comparison with intraarterial digital subtraction angiography. J Neurosurg. 2003;98:828-836.
65. Wintermark M, Thiran JP, Maeder P, et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol. 2001;22:905-914.
66. Fisher CMF. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol. 1951;10:92-93.
67. Fenichel BD, ed. Intracerebral Hemorrhage in Neurology in Clinical Practice. 2001.
68. Buonanno FS, Moody DM, Ball MR. CT scan findings in cerebral sinovenous occlusion. Neurology. 1979;29:1433-1434.
69. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30:536-550.
70. Cole FM, Yates PO. The occurrence and significance of intracerebral micro-aneurysms. J Pathol Bacteriol. 1967;93:393-411.
71. Freytag E. Fatal hypertensive intracerebral haematomas: a survey of the pathological anatomy of 393 cases. J Neurol Neurosurg Psychiatry. 1968;31:616-620.
72. Hart RG, Easton JD. Hemorrhagic infarcts. Stroke. 1986;17:586-589.
73. Takebayashi S, Kaneko M. Electron microscopic studies of ruptured arteries in hypertensive intracerebral hemorrhage. Stroke. 1983;14:28-36.
74. Takebayashi S. Ultrastructural morphometry of hypertensive medial damage in lenticulostriate and other arteries. Stroke. 1985;16:449-453.
75. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
76. Zazulia AR, Diringer MN, Derdeyn CP, et al. Progression of mass effect after intracerebral hemorrhage. Stroke. 1999;30:1167-1173.
77. Yang GY, Betz AL, Chenevert TL, et al. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg. 1994;81:93-102.
78. Carhuapoma JR, Wang PY, Beauchamp NJ, et al. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke. 2000;31:726-732.
79. Carhuapoma JR, Barker PB, Hanley DF, et al. Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2002;23:1322-1326.
80. Fujii Y, Takeuchi S, Harada A, et al. Hemostatic activation in spontaneous intracerebral hemorrhage. Stroke. 2001;32:883-890.
81. Tuhrim S, Dambrosia JM, Price TR, et al. Prediction of intracerebral hemorrhage survival. Ann Neurol. 1988;24:258-263.
82. Tuhrim S, Dambrosia JM, Price TR, et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991;29:658-663.
83. Tuhrim S, Horowitz DR, Sacher M, et al. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med. 1995;23:950-954.
84. Tuhrim S, Horowitz DR, Sacher M, et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999;27:617-621.
85. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
86. Portenoy RK, Lipton RB, Berger AR, et al. Intracerebral haemorrhage: a model for the prediction of outcome. J Neurol Neurosurg Psychiatry. 1987;50:976-979.
87. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305.
88. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project - 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990;53:16-22.
89. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891-897.
90. Fernandes H, Gregson BA, Siddique MS, et al. Testing the ICH score. Stroke. 2002;33:1455-1456.
91. Jamora RD, Kishi-Generao EM Jr, Bitanga ES, et al. The ICH score: predicting mortality and functional outcome in an Asian population. Stroke. 2003;34:6-7.
92. Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56:766-772.
93. Fiebach JB, Schellinger PD, Gass A, et al. Kompetenznetzwerk Schlaganfall B5. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35:502-506.
94. Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology. 1998;51:447-451.
95. Crim JM, Brodke KD. Clearance of the cervical spine in multitrauma patients: the role of advanced imaging. Semin Ultrasound CT MR. 2001;22:283-305.
96. Mayer SA, Sacco RL, Shi T, et al. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379-1384.
97. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;1057:18-24.
98. Ohwaki K, Yano E, Nagashima H, et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35:1364-1367.
99. Meyer JB. Medical treatment of spontaneous intracranial hemorrhage by use of hypotensive drugs. Neurology. 1962;12:36-47.
100. Dandapani BK, Suzuki S, Kelley RE, et al. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995;26:21-24.
101. Qureshi AI, Bliwise DL, Bliwise NG, et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480-485.
102. Tuhrim S. Prognosis. In: Feldmann E, ed. Intracerebral Hemorrhage. Armonk: Futura; 1994:333-343.
103. Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med. 1993;21:1591-1603.
104. Adams RE, Powers WJ. Management of hypertension in acute intracerebral hemorrhage. Crit Care Clin. 1997;13:131-161.
105. Dirnagl U, Pulsinelli W. Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cerebr Blood Flow Metab. 1990;10:327-336.
106. Mayer SA, Lignelli A, Fink ME, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage. Stroke. 1998;29:1791-1798.
107. Diringer MN, Adams RE, Dunford-Shore JE, et al. Cerebral blood flow is symmetrically reduced in patients with intracerebral hemorrhage. Neurology. 1998;50:A338-A339. (Deleted in proof.)
108. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke. 2003;34:224-229.
109. Lin JH, WC, Tarantino M, et al. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg. 2003;98:737-740.
110. Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Disease-A-Month. 2003;49:39-48.
111. 110a. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
112. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA stroke study. N Engl J Med. 1995;333:1581-1587.
113. Patel SMA. Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovas Dis. 1999;42:217-233.
114. Boulis NM, Bobek MP, Schmaier A, et al. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999;45:1113-1118; discussion 1118-1119.
115. Buring JE, Bogousslavsky J, Dyken M. Aspirin and stroke. Stroke. 1998;29:885-886.
116. He J, Whelton PK, Vu B, et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998;280:1930-1935.
117. Wong KS, Mok V, Lam WW, et al. Aspirin-associated intracerebral hemorrhage: clinical and radiologie features. Neurology. 2000;54:2298-2301.
118. Schwarz S, Hafner K, Aschoff A, et al. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354-361.
119. Sung CY, Chu NS. Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1989;52:1273-1276.
120. Berger AR, Lipton RB, Lesser ML, et al. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology. 1988;38:1363-1365.
121. Cocito L, Nizzo R, Bisio N, et al. Epileptic seizures heralding intracerebral hemorrhage. Stroke. 1994;25:2292-2293.
122. Weisberg LA, Shamsnia M, Elliott D. Seizures caused by nontraumatic parenchymal brain hemorrhages. Neurology. 1991;41:1197-1199.
123. Passero S, Rocchi R, Rossi S, et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175-1180.
124. Faught E, Peters D, Bartolucci A, et al. Seizures after primary intracerebral hemorrhage. Neurology. 1989;39:1089-1093.
125. Vespa PK OP K, Shah M, Mirabelli J, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441-1446.
126. Cervoni L, Artico M, Salvati M, et al. Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev. 1994;17:185-188.
127. Yundt KD, Diringer MN. The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury. Crit Care Clin. 1997;13:163-184.
128. Muizelaar JP, Lutz HA 3rd, Becker DP. Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg. 1984;61:700-706.
129. Vinas FC, Dujovny M, Hodgkinson D. Early hemodynamic changes at the microcirculatory level and effects of mannitol following focal cryogenic injury. Neurol Res. 1995;17:465-468.
130. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26:440-446.
131. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated ultracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44:1055-1063; discussion 1063-1054.
132. The use of barbiturates in the control of intracranial hypertension. Brain Trauma Foundation. J Neurotrauma. 1996;13:711-714.
133. Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med. 2002;30:2481-2488.
134. Clifton GL. Systemic hypothermia in treatment of severe brain injury: a review and update. J Neurotrauma. 1995;12:923-927.
135. Krieger DW, De Georgia MA, Abou-Chebl A, et al. Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke. 2001;32:1847-1854.
136. Badjatia N, O'Donnell J, Baker J, et al. Achieving normothermia in febrile subarachnoid hemorrhage patients: feasibility and safety of a novel intravascular cooling catheter. Crit Care Med. 2003.
137. Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987;316:1229-1233.
138. Elkind MS, Mohr JP. Cerebellar hemorrhage. New Horizons. 1997;5:352-358.
139. Uno M, Tomida K, Shichijo F, et al. Surgical treatment for hypertensive cerebellar hemorrhage-indication and characteristics of stereotaxic aspiration surgery. No Shinkei Geka. 1988;16:41-48.
140. Wijdicks EF, St. Louis EK, Atkinson JD, et al. Clinician's biases toward surgery in cerebellar hematomas: an analysis of decision-making in 94 patients. Cerebrovasc Dis. 2000;10:93-96.
141. Fernandes HM, Gregson B, Siddique S, et al. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke. 2000;31:2511-2516.
142. Fayad PB, Awad IA. Surgery for intracerebral hemorrhage. Neurology. 1998;51(suppl 3):S69-S73.
143. Hankey GJ, Hon C. Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke. 1997;28:2126-2132.
144. McKissock WRA, Taylor J. Primary intracerebral hemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet. 1961;2:221-226.
145. Batjer HH, Reisch JS, Allen BC, et al. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol. 1990;47:1103-1106.
146. Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg. 1989;70:755-758.
147. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke. 1999;30:1833-1839.
148. Piotrowski WP, Rochowanski E. Operative results in hypertensive intracerebral hematomas in patients over 60. Gerontology. 1996;42:339-347.
149. 147a. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomized trial. Lancet. 2005;365:387-397.
150. Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology. 1998;50:519-523.
151. Schwarz S, Schwab S, Steiner HH, et al. Fibrinolysis of intraventricular hematoma with rt-PA. Nervenarzt. 1999;70:123-130.
152. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30- Day survival. Stroke. 2000;31:841-847.
153. Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34-39.
154. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669-674.
155. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001;57:1603-1610.
156. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
157. Boeer A, Voth E, Henze T, et al. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54:466-467.
158. Bertram M, Bonsanto M, Hacke W, et al. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol. 2000;247:209-214.
159. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol. 2000;57:1710-1713.